Short answer
Chewy Inc (CHWY) filed its Q4 2019 10-Q quarterly report on Dec 9, 2019 for the quarter ended Nov 3, 2019.
Chewy Inc Q4 2019 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1.23B, up 40.4% YoY from $875.6M
- Gross margin 23.7% vs 19.6% YoY, driven by pharmacy and private brands
- Other revenue $146.9M, up 133.6%, best-performing product line
- Hardgoods revenue $172.0M, up 28.8%, weakest product-line growth
- Operating cash flow $1.6M vs negative $43.2M; capital expenditures $14.4M, cash $135.9M at quarter-end
- Management expects liquidity sufficient for at least twelve months, with $300M ABL capacity and no borrowings outstanding
Risk Factors
- No material changes: legal matters and advertising and services commitments unchanged from Prospectus disclosures
- IPO completion: new public-company risk from Class B shares carrying ten votes per share
- ABL Credit Facility: new covenant risk, including minimum fixed-charge coverage ratio of 1.0:1.0
- Operating leases: $217.072 million liabilities with maturities extending through 2031
- Ongoing losses: $191.430 million net loss for the 39 weeks ended November 3, 2019
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Chewy Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.